| 摘要 |
<p>Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a therapeutic amount of a Δ5-Androstene-3β-ol-17-one having a C7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.</p> |
